ELIZABETH WALTERS: Open Payments
NPI 1568117463 · LAUREL, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$251 in 14 payments from 9 companies in 2025. Trend: 2023 $336 · 2024 $230 · 2025 $251
Food & beverage: $251
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| Novo Nordisk Inc | 2 | $35 |
| Lilly USA, LLC | 2 | $34 |
| ABBVIE INC. | 2 | $32 |
| Purdue Pharma L.P. | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: Auvelity, TRINTELLIX, Ozempic, MOUNJARO, NALMEFENE HYDROCHLORIDE, JARDIANCE, UBRELVY, Kerendia.
Industry payments across MS — which companies pay providers there.
